Patents Assigned to Toxcure. LLC
-
Publication number: 20130236497Abstract: The present invention provides a method of treating a cancer using a neurotoxin, preferably Botulinum toxin (“BTX”). The application of a neurotoxin around a cancer acts to decrease the contractile forces of the muscles surrounding a neoplasm which normally squeeze cancer cells through efferent channels leaving the cancer vicinity to distant sites. Also, the application of the toxin at sites distant from the cancer enhances cellular and humoral immunologic functions which further contributes to cancer cell death and spread. Following administration of botulinum toxin around and distant to a cancer, it is noticed that local, regional, and distant spread is reduced or eliminated. Immunomodulation with botulinum toxin is also valuable in treating other disease that may or may not be associated with cancers, such as viral-induced growths, viral conditions, fungal disease, chronic wounds, graft versus host disease, autoimmune disease, and HIV.Type: ApplicationFiled: May 2, 2013Publication date: September 12, 2013Applicant: TOXCURE, LLCInventor: Christopher Shaari
-
Publication number: 20130085472Abstract: The invention is directed to a nasal delivery device comprising one or more microneedles, and to methods of nasally administering a composition with a nasal delivery device comprising one or more microneedles. In certain embodiments, the nasal delivery device comprises a substrate for administration of a composition to the nasal and/or sinus mucosa, wherein the substrate is non-absorbent and comprises one or more microneedles. In some embodiments, the nasal delivery device comprises a reservoir comprising one or more therapeutic agents, wherein the reservoir is in fluid communication with one or more microneedles.Type: ApplicationFiled: March 9, 2011Publication date: April 4, 2013Applicant: Toxcure, LLCInventor: Christopher Shaari
-
Publication number: 20120231034Abstract: The present invention provides methods for treating a substance addiction- related behavior in a patient with a substance addiction, comprising the step of locally administering a therapeutically effective amount of a botulinum neurotoxin to a location on the patient's body or in the vicinity of the area which comes into contact with a smoking tool or addictive substance, thereby altering, reducing or eliminating sensations associated with behaviors associated with substance addiction. Botulinum neurotoxin may be administered to a dermal, subdermal, mucosal or submucosal location or to a muscle area or in the vicinity of the location to which a smoking tool or addictive substance contacts.Type: ApplicationFiled: September 30, 2010Publication date: September 13, 2012Applicant: Toxcure, LLCInventor: Christopher Shaari
-
Publication number: 20120122129Abstract: The present invention relates to an assay which can be used on nasal secretions. The assay is used to determine the cause of nasal secretions, for example whether the secretions are due to an allergic reaction or a non-allergic reaction.Type: ApplicationFiled: January 23, 2012Publication date: May 17, 2012Applicant: Toxcure, LLCInventor: Christopher M. SHAARI
-
Patent number: 8105794Abstract: The present invention relates to an assay which can be used on nasal secretions. The assay is used to determine the cause of nasal secretions, for example whether the secretions are due to an allergic reaction or a non-allergic reaction.Type: GrantFiled: February 4, 2011Date of Patent: January 31, 2012Assignee: Toxcure LLCInventor: Christopher Shaari
-
Publication number: 20110177529Abstract: The present invention relates to an assay which can be used on nasal secretions. The assay is used to determine the cause of nasal secretions, for example whether the secretions are due to an allergic reaction or a non-allergic reaction.Type: ApplicationFiled: February 4, 2011Publication date: July 21, 2011Applicant: Toxcure, LLCInventor: Christopher M. SHAARI
-
Patent number: 7888049Abstract: The present invention relates to an assay which can be used on nasal secretions. The assay is used to determine the cause of nasal secretions, for example whether the secretions are due to an allergic reaction or a non-allergic reaction.Type: GrantFiled: February 7, 2007Date of Patent: February 15, 2011Assignee: Toxcure. LLCInventor: Christopher M. Shaari